FDA opens US to Lyrica generics
24-07-2019
Pfizer expects $1.9bn loss due to patent expirations
31-07-2018
Pfizer allows Teva’s generic Viagra
19-12-2013
no_limit_pictures / iStockphoto.com
American pharmaceutical company Pfizer warned investors of little revenue growth to come in 2019, owing partly to expiring exclusivity rights on drugs including Viagra and the seizure medicine Lyrica.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Pfizer, Viagra, generics, biosimilars, patent expiration, exclusivity, pharmaceuticals, Lyrica
